News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
529,356 Results
Type
Article (13217)
Company Profile (150)
Press Release (515987)
Multimedia
Podcasts (6)
Webinars (6)
Section
Business (179020)
Career Advice (476)
Deals (27288)
Drug Delivery (15)
Drug Development (56233)
Employer Resources (24)
FDA (10960)
Job Trends (9650)
News (256238)
Policy (20424)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (6)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (1055)
Academic (1)
Accelerated approval (28)
ADA (19)
Adcomms (1)
Allergies (105)
Alliances (37026)
ALS (115)
Alzheimer's disease (1122)
Antibody-drug conjugate (ADC) (310)
Approvals (11654)
Artificial intelligence (390)
ASCO (181)
Autoimmune disease (222)
Automation (53)
Bankruptcy (275)
Best Places to Work (7587)
BIO (37)
Biologics (2)
BIOSECURE Act (2)
Biosimilars (120)
BioSpace Insights (24)
Biotechnology (96)
Bladder cancer (165)
Brain cancer (31)
Breast cancer (576)
Cancer (4157)
Cardiovascular disease (247)
Career advice (409)
Career pathing (4)
CAR-T (199)
CDC (6)
CDMO (18)
Celiac Disease (2)
Cell therapy (537)
Cervical cancer (41)
Clinical research (50439)
Collaboration (1472)
Commercialization (4)
Company closure (2)
Compensation (1501)
Complete response letters (35)
COVID-19 (1173)
CRISPR (75)
C-suite (844)
Cystic fibrosis (97)
Data (6139)
Denatured (5)
Depression (104)
Dermatology (67)
Diabetes (374)
Diagnostics (5800)
Digital health (41)
Diversity (2)
Diversity, equity & inclusion (5)
Drug discovery (203)
Drug pricing (11)
Drug shortages (5)
Duchenne muscular dystrophy (179)
Earnings (76108)
Editorial (1)
Employer branding (5)
Employer resources (23)
Events (92209)
Executive appointments (776)
FDA (13867)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (18)
Frontotemporal dementia (23)
Funding (1052)
Gene editing (141)
Generative AI (15)
Gene therapy (382)
GLP-1 (387)
Government (1647)
Grass and pollen (3)
Guidances (300)
Healthcare (10576)
Hematology (109)
HIV (60)
Huntington's disease (22)
IgA nephropathy (67)
Immunology and inflammation (106)
Immuno-oncology (64)
Indications (174)
Infectious disease (1398)
Inflammatory bowel disease (131)
Inflation Reduction Act (4)
Influenza (99)
Intellectual property (268)
Interviews (64)
IPO (12880)
IRA (3)
Job creations (2430)
Job search strategy (389)
JPM (6)
Kidney cancer (17)
Labor market (5)
Layoffs (90)
Leadership (3)
Legal (5544)
Licensing (14)
Liver cancer (53)
Longevity (22)
Lung cancer (565)
Lymphoma (296)
Machine learning (32)
Management (7)
Manufacturing (662)
Marketing (8)
MASH (124)
Medical device (9414)
Medtech (9567)
Mergers & acquisitions (15517)
Metabolic disorders (764)
mRNA (73)
Multiple sclerosis (109)
NASH (5)
Neurodegenerative disease (246)
Neuropsychiatric disorders (42)
Neuroscience (2048)
NextGen: Class of 2026 (3572)
Non-profit (1329)
Now hiring (16)
Obesity (242)
Opinion (35)
Ovarian cancer (178)
Pain (179)
Pancreatic cancer (219)
Parkinson's disease (228)
Partnered (20)
Patents (499)
Patient recruitment (533)
Peanut (36)
People (44684)
Pharmaceutical (34)
Pharmacy benefit managers (9)
Phase 1 (16239)
Phase 2 (22316)
Phase 3 (15417)
Pipeline (8058)
Policy (25)
Postmarket research (1746)
Preclinical (7029)
Press Release (42)
Prostate cancer (218)
Psychedelics (7)
Radiopharmaceuticals (210)
Rare diseases (625)
Real estate (4116)
Recruiting (9)
Regulatory (16778)
Reports (23)
Research institute (1101)
Resumes & cover letters (61)
Rett syndrome (43)
RNA editing (5)
RSV (51)
Schizophrenia (104)
Series A (177)
Series B (129)
Service/supplier (5)
Sickle cell disease (64)
Spinal muscular atrophy (96)
Sponsored (11)
Startups (2324)
State (1)
Stomach cancer (4)
Supply chain (63)
Tariffs (1)
The Weekly (1)
Vaccines (395)
Venture capital (18)
Weight loss (87)
Women's health (92)
Worklife (1)
Date
Last 7 days (463)
Last 30 days (1471)
Last 365 days (20302)
2026 (13940)
2025 (20479)
2024 (24641)
2023 (28593)
2022 (37401)
2021 (40333)
2020 (37128)
2019 (26368)
2018 (19824)
2017 (21214)
2016 (20511)
2015 (26664)
2014 (23727)
2013 (20152)
2012 (22138)
2011 (22404)
2010 (21878)
Location
Africa (328)
Alabama (80)
Alaska (3)
Arizona (326)
Arkansas (11)
Asia (21639)
Australia (2894)
California (12555)
Canada (3321)
China (613)
Colorado (512)
Connecticut (436)
Delaware (247)
Europe (35056)
Florida (1862)
Georgia (395)
Hawaii (3)
Idaho (47)
Illinois (769)
India (62)
Indiana (382)
Iowa (16)
Japan (436)
Kansas (113)
Kentucky (42)
Louisiana (34)
Maine (35)
Maryland (1342)
Massachusetts (8321)
Michigan (319)
Minnesota (609)
Mississippi (4)
Missouri (138)
Montana (27)
Nebraska (12)
Nevada (129)
New Hampshire (65)
New Jersey (2903)
New Mexico (18)
New York (2971)
North Carolina (1444)
North Dakota (4)
Northern California (6271)
Ohio (353)
Oklahoma (15)
Oregon (19)
Pennsylvania (2359)
Puerto Rico (22)
Rhode Island (36)
South America (539)
South Carolina (79)
South Dakota (1)
Southern California (5232)
Tennessee (143)
Texas (2051)
United States (41534)
Utah (387)
Vermont (1)
Virginia (171)
Washington D.C. (42)
Washington State (1006)
West Virginia (1)
Wisconsin (94)
Wyoming (2)
529,356 Results for "asymchem laboratories inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Asymchem’s Dunhua 2 Carbapenem Manufacturing Site Successfully Completes its First FDA Inspection for Continuous Manufacturing of an API
July 26, 2026
·
2 min read
Business
Asymchem Secures Former Pfizer Sandwich, UK, Development and API Pilot Plant Manufacturing Facilities
Asymchem Laboratories Co., Ltd. announced that it will operate the former Pfizer U.K. small molecule API pilot plant and part of the development laboratories through a new lease agreement between Asymchem and Discovery Park, establishing Asymchem’s first manufacturing footprint in Europe.
May 21, 2024
·
3 min read
Business
Asymchem Appoints Dr. Cheng Yi Chen as CTO of Small-Molecule Sector
In line with Asymchem’s continuous strategic layout and development, the organization has welcomed Dr. Cheng Yi Chen as a senior executive.
June 26, 2024
·
2 min read
Business
Asymchem Welcomes Franck Mevellec as Senior Director, Business Development
Asymchem, a leading global CDMO, is excited to announce the appointment of Franck Mevellec as senior director, business development.
May 29, 2024
·
1 min read
Press Releases
Diazyme Laboratories, Inc. Announces FDA 510(k) Clearance for Lipoprotein(a) Molarity Assay
June 19, 2026
·
1 min read
Press Releases
Asymchem’s Fully Automated Peptide Production Lines Set New Benchmarks as Large-Scale Capacity Continues to Grow
November 13, 2024
·
2 min read
Press Releases
Charles River Laboratories Announces Second-Quarter 2026 Results
August 5, 2026
·
19 min read
Business
Asymchem Announces Opening of R&D site near Boston, Massachusetts
Asymchem Laboratories Co., Ltd. announced their opening of a new site in Woburn, Massachusetts – Asymchem Boston, a wholly owned subsidiary of Asymchem Group, as an important step to expand Asymchem’s global footprint.
December 19, 2022
·
2 min read
Press Releases
Laboratory Modernization Strengthens QPS Holdings, LLC’s Long-Term Commitment to Elemental Bioanalysis
August 31, 2026
·
3 min read
Press Releases
Bruker Announces Strategic Collaboration with Atinary Technologies to Advance Self-Driving Laboratories
August 11, 2026
·
4 min read
1 of 52,936
Next
